Strategic initiative to accelerate practical quantum computing through cross-platform execution to reach fault-tolerant performance optimization

Tel Aviv, Israel, June 18, 2026 (GLOBE NEWSWIRE) -- Quantum X Labs Inc. (NASDAQ:QXL) ("Quantum X" or the "Company"), an advanced technologies company, today announced the launch of a new integrated quantum computing program that combines the company's proprietary quantum algorithms for clinical trial data analysis, as part of our CliniQuantum platform, with its advanced Quantum Error Correction (QECC) Decoder technology. The initiative is designed to maximize computational accuracy and reliability by using the company's quantum algorithm across multiple quantum computing environments combined with its decoder in order to optimize a path toward scalable, fault-tolerant quantum applications.

Under the program, Quantum X Labs will execute its CliniQuantum platform, Quantum Algorithm (patent pending), on a variety of quantum computing platforms, including leading quantum processors and hybrid GPU–quantum computing systems. The objective is to evaluate and optimize both the algorithmic performance as well as the decoder capabilities across diverse computational environments while leveraging the unique strengths of each platform.